Meridian Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,531
Closed -$242K 409
2021
Q3
$242K Hold
2,531
0.03% 346
2021
Q2
$315K Sell
2,531
-24
-0.9% -$2.86K 0.04% 293
2021
Q1
$337K Hold
2,555
0.05% 267
2020
Q4
$338K Sell
2,555
-916
-26% -$111K 0.05% 244
2020
Q3
$353K Buy
+3,471
New +$300K 0.09% 170
2020
Q1
Sell
-3,780
Closed -$349K 216
2019
Q4
$349K Sell
3,780
-2,978
-44% -$262K 0.17% 136
2019
Q3
$611K Buy
6,758
+3,048
+82% +$347K 0.29% 70
2019
Q2
$4.38K Buy
3,710
+30
+0.8% +$3.02K 0.18% 93
2019
Q1
$319K Buy
+3,680
New +$313K 0.15% 133

Other funds holding EXAS

Meridian Wealth Management's EXAS Position: Q4 2021 in Review

Meridian Wealth Management sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 2,531 shares — an estimated $242K sold.

Meridian Wealth Management first reported a position in EXAS in Q1 2019 and held it in 9 quarters. The position peaked at $611K in Q3 2019. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Meridian Wealth Management reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • Meridian Wealth Management sold 2,531 Exact Sciences shares in Q4 2021, an estimated $242K.
  • Meridian Wealth Management first reported a position in Exact Sciences in Q1 2019 and held it in 9 quarters.
  • Meridian Wealth Management's Exact Sciences position peaked at $611K in Q3 2019.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Meridian Wealth Management's 13F filing for Q4 2021, filed 27 Jan 2022.